Halofantrine, with CAS number 69756-53-2, is a pharmaceutical substance used for the treatment of malaria. It belongs to the class of antimalarial agents and is primarily used to treat infections caused by Plasmodium falciparum, which is a severe and potentially fatal form of malaria.
Halofantrine is available in tablet form and is administered orally. It works by targeting the parasite’s ability to reproduce and survive in the body. The substance interferes with the formation of hemozoin, a toxic byproduct of hemoglobin digestion by the parasites, leading to their death.
While halofantrine has shown effectiveness in treating malaria, it is recommended to be used cautiously due to its potential side effects. Common side effects may include gastrointestinal discomfort, vomiting, and dizziness. It may also cause cardiac complications, such as QT prolongation, which can lead to abnormal heart rhythms.
As with any pharmaceutical substance, it is important to carefully follow the prescribed dosage and duration